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ABSTRACT  Unlabeled  collagenous  proteins were quantified  as inhibitors of binding of native, 
soluble,  radioiodinated type I collagen  to the fibroblast surface. Collagen  types IV, V, a minor 
cartilage  isotype  (1~2c~3c~), and  the  collagenlike  tail  of  acetylcholinesterase  did  not  inhibit 
binding.  Collagen  types  II  and  III  behaved  as  competitive  inhibitors  of  type  I  binding. 
Denaturation  of native collagenous  molecules  exposed cryptic inhibitory determinants  in the 
separated  constituent  ~  chains.  Inhibition  of  binding  by  unlabeled  type  I collagen  was  not 
changed  by enzymatic removal  of the telopeptides.  Inhibitory determinants  were detected  in 
cyanogen  bromide-derived  peptides  from  various  regions of  helical  ~1(I)  and  al(lll)  chains. 
The  aminoterminal  propeptide  of  chick  procd(I)  was  inhibitory  for  binding,  whereas  the 
carboxyterminal  three-chain  propeptide  fragment  of  human  type I procollagen  was  not. The 
data  are  discussed  in  terms  of  the  proposal  that  binding  to  surface  receptors  initiates  the 
assembly of periodic collagen  fibrils in vivo. 
The binding of type I collagen to fibroblasts is considered to 
be specific because the radiolabeled ligand is readily displaced 
by unlabeled type I collagen but not by noncollagenous pro- 
teins, nor by every molecule containing some collagen structure 
(1). In the present study, binding inhibition measurements have 
further  defined  ligand  specificities  with  respect  to  collagen 
types, native triple helical assembly, and regions of procollagen 
and collagen chains that contain binding determinants. 
MATERIALS  AND  METHODS 
Binding Inhibition Assays 
Swiss mouse 3T3 fibroblast cultures were used in standard binding assays as 
described  (1,  2).  Unlabeled  lathyritic  rat  skin  (LRSC)  and  other  unlabeled 
collagenous proteins were dissolved in 0.05 M  Tris HCI-0.15 M  NaCI pH 7.5 
buffer at 1-2 mg/ml. Protein concentrations of the stock solutions were computed 
from the difference in absorbances at 215 and 225 nm of appropriate dilutions of 
the stock (3). For each experiment, increasing amounts (0-100 #g) of unlabeled 
LRSC and of putative binding proteins were each premixed with a fixed amount 
of ~zr'I-LRSC (~ 130,000 cpm) in 2 ml of binding buffer (Dulbecco's modification 
of Eagle's medium with half bicarbonate concentration, 0.05 M HEPES, pH 7.2 
and 2.5 mg/ml bovine serum albumin). The solutions were warmed at 37°C for 
30 min,  cooled  to  room temperature  (26°C)  and added  to  washed,  replicate 
confluent cultures of 3T3 fibroblasts. After a  2-h incubation at 26°C, the cell 
layers were rapidly washed and lysed, and the radioactivity specifically bound to 
the ceils was measured. Percentage inhibition of binding at each protein concen- 
tration was computed by: 
1  cpm bound with unlabeled protein  ~  × 
c~~  protein,/  102 
Limited Digestion of LRSC with Pepsin and 
a-Chymotrypsin 
Pepsin  was  purchased  from  Sigma  Chemical  Co.,  St.  Louis,  MO  and a- 
chymotrypsin from Worthington Biochemical Corp., Freehold, NJ. Pepsin diges- 
tion was done according to  the  procedures of Leibovich and Weiss  (4)  and 
Helseth and Veis (5). Digestion with a-chymotrypsin was done by the procedure 
of Bornstein et al. (6).  Control samples without enzyme additions were carried 
through all the procedures. Samples were finally dissolved in Tris buffer and 
tested as inhibitors of binding as described above. 
SDS PAGE 
Samples were dissolved in sample buffer containing 2% SDS,  10% glycerol. 
0.001% bromphenol blue in 0.0625 M Tris HCI, pH 6.8. After heating at 100°C 
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and, after development,  the gels were stained  with Coomassie Blue. 
Materials 
Collagenous  proteins were generously  donated by the following  investigators: 
Dr. Terrone L. Rosenberry,  Case Western Reserve University,  Cleveland,  OH, 
the collagenlike  tail of acetylcholinesterase;  Dr. Jerome Seyer, Veterans Admin- 
istration Medical  Center, Memphis,  TN, cyanogen  bromide  peptides  of collagen; 
Dr. George Martin,  National Institute  of Dental Research. Bethesda, MD, LRSC 
and rodent collagen types 11 and  IV; Dr.  Bjrrn  R.  Olsen, Department of 
Biochemistry,  College  of Medicine  and Dentistry  of New Jersey-Rutgers  Medical 
School, Piscataway, N  J, the aminoterminal  propeptide of chick pro a l(I). 
The synthetic  peptides DNP-Pro-GIn-GIy-Ile-AIa-GIy-GIn-D-Arg  and DNP- 
Pro-Leu-Gly-lle-Ala-Gly-Arg-NH2  were purchased from the Peptide Institute, 
Protein Research Foundation,  Osaka, Japan. 
RESULTS 
Specificities: Collagen Structure, Collagen  Types, 
and Native Helicity 
Potential competitors for 12~I-LRSC  binding sites were com- 
pared to the unlabeled LRSC in inhibition assays as described 
in Materials and Methods. That general collagen structure does 
not ensure binding to or blocking of type I  sites is shown in 
Fig.  1.  In this instance the putative competitor was the colla- 
genlike tail of acetylcholinesterase (8, 9). Additions of up to 20 
t~g of this unlabeled protein did not significantly inhibit binding 
of the  radioactive ligand, whereas 20/xg  of unlabeled LRSC 
produced  78%  inhibition of binding.  Clq,  the  complement 
component containing some  collagen structure,  also  fails to 
inhibit type I binding (1). 
Native  Collagen types II,  III,  IV,  V,  and a  minor isotype 
present in cartilage but distinct from type II collagen (10) were 
tested  in binding inhibition assays (Fig. 2).  These data show 
that  unlabeled type II and type I  collagens cause equivalent 
inhibition whereas unlabeled type III collagen is a  somewhat 
less efficient inhibitor of binding. The  much lower levels of 
inhibition produced by the other collagen types are considered 
to be of doubtful significance. 
Graphical analyses of binding data were  performed  to de- 
termine whether collagen types II and III acted as competitive 
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F~GURE  1  Acetylcholinesterase  as  a 
competitor of  12SI-LRSC binding.  In- 
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and the collagenlike tail of acetylcho-  ~ 
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FIGURE  2  Native  collagen  types 
as inhibitors of '251-LRSC binding. 
Composite of  binding  inhibition 
experiments  performed  with  the 
following  native  collagen  types: 
type  I,  LRSC; type  II  from  a  rat 
chondrosarcorna;  type  III,  from 
human placenta; type IV, from the 
mouse EHS sarcoma; la2a3a car- 
tilage isotype, from  human  carti- 
lage, and type V, from human pla- 
centa. 
or noncompetitive inhibitors of type I binding. Fig. 3 presents 
Scatchard plots of type I binding with and without the addition 
of 5  #g  (17.5  pmol)  of type  II  collagen.  Calculation of the 
slopes showed that inhibition was accompanied by an increase 
in the binding dissociation constant (KD) from 7.5 X  10  -9 M  to 
1.7 x  10  -8 M. The common abscissal intercept for the two lines 
indicates that the number of cell binding sites was not changed 
by the inhibition. Fig. 4 is a  Hanes-Woolf plot (11,  12) of the 
same data and it, like the Scatchard plot, is typical for a form 
of competitive inhibition. Qualitatively similar plots were ob- 
tained for inhibition by type III collagen. 
The collagen types tested in the experiments of Fig. 2 were 
native triple helical molecules. It is of interest to know whether 
native helicity critically determines binding specificity. If triple 
helicity  is  critical  for  binding, the  separated  (denatured)  a 
chains should yield different binding inhibition data than the 
assembled parent molecules. In the experiments presented in 
Fig. 5, the three denatured a  chains from the minor cartilage 
isotype and the denatured a 1 and a2 chains of type V collagen 
were individually tested in binding inhibition assays. Whereas 
the parent triple helical molecules did not inhibit binding (see 
Fig. 2), each chain class of the cartilage isotype and the a2(V) 
chain gave equivalent or significant inhibition relative to the 
LRSC  standard.  Denatured  reduced  and  alkylated  type  III 
chains were better inhibitors of type I binding than native III, 
and nondenatured reduced and alkylated type IV collagen did 
not inhibit binding (data not shown). We conclude that triple 
helicity can confer binding specificity and that denaturation of 
a  chains can expose additional binding determinants. 
20~t,Q~  FIGURE  3  Type  II  inhibi- 
tion:  scatchard  plot.  In- 
15  creasing  amounts  (0-100 
o  "  /~g)  of  unlabeled  LRSC 
were premixed with a fixed 
amount  of  '2%/RSC  (0.16 
5[  ~  pmol,  118,000 cpm)  in  the 
L  J  ,  presence  (O)  and  absence 
0  0.5  to  1.5  2.0  2.5  3.0  (O)  of 5 #g  (17.5 pmol)  of 
B (PICOMOLES)  unlabeled type II collagen. 
The respective mixtures were presented to  replicate plates of 3T3 
fibroblasts and specific binding measured after 2.5 h at 26°C.  Pico- 
moles of type I collagen (radiolabeled and unlabeled) bound  (B) 
and free (F) were calculated. 
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FIGURE  4  Type ll inhibition: Hanes-Woolf plot. Data from exper- 
iment of Fig. 3. (L)  Picomoles of type I collagen ligand (labeled and 
unlabeled) added. (B)  Picomoles of type I collagen ligand (labeled 
and  unlabeled) bound.  (O),  5/xg (17.5 pmol)  of unlabeled type II 
collagen added as inhibitor.  (z~), in absence of type II inhibitor. 
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The telopeptides are short (10-25 residues) nonhelical exten- 
sions at the ends of the collagen a  chains. Collagen molecules 
in solution can self-assemble to form native fibrils (14) and the 
initiation ("nucleation") of such self-assembly seems to depend 
upon a thermally induced conformational change in the amino 
terminal  telopeptides  (5).  Collagen  binding  to  the  fibroblast 
also requires thermal activation of the ligand, and such binding 
has been proposed as an initiating event for fibrillogenesis (1, 
2).  Accordingly,  experiments  were  performed  to  determine 
whether the telopeptides were necessary for binding of  collagen 
to  the  fibroblast.  The  tetopeptides  were  first  removed from 
unlabeled LRSC by limited digestion with a-chymotrypsin or 
pepsin. Fig. 6 shows the SDS-polyacrylamide gel patterns given 
by a-chymotrypsin-digested LRSC and  the  control prepara- 
tion. The enzyme-digested collagen contains somewhat fewer 
covalently cross-linked molecules (y and fl forms) and has a 
major  population  of al  and  a2  chains  with  slightly  greater 
mobilities than the control preparation. This result shows that 
the enzyme digested the telopeptides and did not alter the triple 
helix in most of the molecules. Binding inhibition assays were 
performed with enzyme-digested and control LRSC, with and 
without prior thermal activation (37°C, 30 min) of the samples. 
Fig.  7  shows  that,  with  heat  activation,  molecules  lacking 
telopeptides bound as well as intact collagen. In the absence of 
heat activation, neither preparation displayed significant bind- 
ing.  The  latter  result  shows  that  the  requirement  for  heat 
activation  is  independent  of radioiodination  of the  ligand. 
Similar  data  were  obtained  when  the  telopeptides  were  re- 
moved by limited digestion with pepsin. We conclude that the 
telopeptides are not necessary for thermal activation and bind- 
ing of type I collagen to fibroblasts. 
Potential Binding Determinants in Cyanogen 
Bromide-derived Helical Peptides 
Peptides generated by cyanogen bromide cleavage of helical 
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regions ofal type I and III chains were evaluated as inhibitors 
of type I binding. Fig. 8 depicts the positions in the a chains of 
the peptides  tested and quantifies inhibition  by each peptide 
relative to the type I LRSC standard.  The values given below 
the lines are the ratio of LRSC (#g)/peptide  ~g) which pro- 
duced 30% inhibition of t25I-LRSC binding in the same exper- 
iment.  For all of the experiments,  1-2/~g of LRSC regularly 
produced 30% inhibition of binding. Inhibition ratios <0.1 are 
not considered as significant, and a ratio value of zero means 
that addition of 100 ~g of the peptide produced <30% inhibi- 
tion of binding. 
By the test of inhibition,  binding determinants  were identi- 
fied in more than one peptide in each species and type of a l 
chain, and these peptides were variably distributed  along the 
chains from amino to carboxy termini.  Peptides of similar size 
from the same regions of type I a  chains of different species 
varied in binding capacities, for example, human a l(I)-CB8 as 
compared to the homologous peptides of rat and chick. 
The rodent a I(I)-CB7 peptide which includes residues 552- 
822  of the  al  chain  is  notable  for  being  equivalent  on  a 
concentration basis to LRSC as an inhibitor of binding.  The 
same  peptide  has  been reported  to contain  the determinants 
for attachment of fibronectin to ctl (I) but the following obser- 
vations indicate  that  ~zSI-LRSC is  not binding to fibronectin 
on the  fibroblast  surface  (a)  aI(I)-CB7 has  been  claimed  to 
contain the sole binding site  for fibronectin (15),  but the data 
of Fig.  8  show  that  peptides  positioned  elsewhere  in  al(I) 
chains can significantly inhibit binding of ~25I-LRSC. (b) Crit- 
ical determinants for binding of a I(I)-CB7 to fibronectin have 
been  localized  to  the  cleavage  site  for  animal  collagenase 
(residues 775-776) and a chymotrypsin-sensitive site  (residues 
779-780)  (15).  However,  two  synthetic  peptides  which  have 
identical sequences to residues 773-780 and 775-778 of al(I), 
respectively, and which serve as substrates for animal collagen- 
ase (16), did not inhibit x2~I-LRSC binding (binding inhibition 
100 
FIGURE  5  Denatured  (x chains  as  ~  Bc 
competitors  of '2SI-LRSC  binding. 
Cartilage  isotype  chains  l(x,  2a,  _g 6c 
and  3~x and  al  and  c~2  chains  of  ~  4c 
type V  collagen were  resolved I~y  ~_ 
carboxymethyl  cellulose  chroma-  20 
tography  under  denaturing  con-  0  ° 
ditions  (13).  The individual  chain 
classes  and  native  LRSC  (I)  were 
tested  as  inhibitors  of  '251-LRSC 
binding. 
FIGURE  6  Gel  electrophoresis  of  LRSC and 
chymotrypsin-modified  LRSC.  Lane  (A): 
LRSC digested with  chymotrypsin  at pH 7.5, 
15°C,  24 h,  at  enzyme/substrate  ratio  of  1/ 
10.  Reaction  stopped  by  cooling  to  4°C, 
addition  of  protease  inhibitors  and  acidifi- 
cation.  Collagen  separated  by  three  cycles 
of precipitation with  NaCI to 7.5%.  Lane (B): 
Control  LRSC. Same protocol, enzyme omit- 
ted. 5 p,g of collagen applied to both  lanes. 
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FIGURE  7  Binding  inhibition  by 
LRSC and chymotrypsin-modified 
LRSC.  Samples  of  Fig.  6  used  as 
inhibitors  of  12%LRSC  binding. 
Chymotrypsin-modified  LRSC 
(O)  and  control  LRSC  (O),  acti- 
vated  at  37°C,  30  min.  Chymo- 
trypsin-modified  LRSC  ([7)  and 
control  LRSC (IlL without thermal 
activation. 
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FIGURE  8  Cyanogen bromide-derived  helical peptides as inhibitors 
of binding.  Linear schematic of helical a chains of coltagen types I 
and III indicating positions, standard numbering (above lines), and 
relative sizes of peptides produced by cyanogen bromide cleavages. 
Only the peptides tested in binding assays  are numbered. Numbers 
below lines are the ratio of p.g LRSC//Lg  peptide that  produced 30% 
inhibition of 1251-LRSC binding.  N and  C, amino and carboxytermini 
of the chains,  respectively. ratios of zero, calculated as for experiments of Fig. 8). More- 
over, human cd(III)-CB5, which also contains the coUagenase 
cleavage site, produced minimal inhibition of binding (see Fig. 
8). 
Potential Binding Determinants in Propeptides 
Collagen is secreted as a  precursor molecule (procollagen) 
that has large polypeptides (propeptides) covalently linked to 
the  terminal  telopeptides  of the  three  helical  ot  chains  of 
collagen.  Type I  procollagen could bind  to  the  cell  surface 
through  the  demonstrated  determinants  in  its  central  triple 
helical region but it is possible that propeptide residues could 
also contribute to procollagen binding. A reasonable candidate 
for a propeptide binding region is the short, collagenlike seg- 
ment  ("Col  3")  in  the  aminoterminal  propeptides  of type  I 
procollagen (see reference 17 for review). When the aminopro- 
peptide isolated from the chick pro al(I) chain (18) was tested 
as an inhibitor of 125I-LRSC binding, it gave a binding inhibi- 
tion ratio of 0.19, indicating some affmity for the cell binding 
site. 
The carboxyterminal propeptides  of type I procoUagen do 
not contain any collagenlike structure and they failed to inhibit 
125I-LRSC binding in the standard assay system. The protein 
tested was a three-chain, disulfide-linked fragment of 100,000 
daltons isolated from human type I procollagen (19). 
DISCUSSION 
Quantitative inhibition assays have further defined the speci- 
ficity of binding of native, soluble radioiodinated type I colla- 
gen to the fibroblast surface. The binding is not inhibited  by 
every collagenous molecule; thus, the collagenlike tail of ace- 
tylcholinesterase and native collagen types IV, V and cartilage 
lct2~t3a do not inhibit binding.  Only native collagen types II 
and III inhibit type I binding, and graphical analyses indicate 
that they act as competitive inhibitors.  These inhibitions can 
be ascribed to interactions with type I cell binding sites  or to 
complexes formed directly with type I collagen. Radioiodinated 
type II collagen binds to the fibroblast (unpublished data), so 
there  is independent  evidence for a  cell binding site  for this 
collagen type. In terms of receptor models, competitive inhi- 
bition can mean that collagens I, II, and III bind to the same 
cell receptor site, to different sites that interact allosterically, or 
to both shared and independent sites. Interactions of collagens 
I, II, and III with a common receptor on the fibroblast can be 
interpreted in the following context. Collagen types I and III 
are synthesized by the fibroblast and the mesenchymal precur- 
sor of the differentiated chondrocyte. Although the latter cell 
type synthesizes only type II collagen, it is prone to dediffer- 
entiate and to switch to the synthesis of collagen types I and 
III (20). The data suggest, therefore, that the same cell binding 
complex is used in the course of these phenotype conversions. 
Previously published  and  less  complete binding inhibition 
data supported the view that the primary structure of collagen 
a  chains determined  the binding specificity of the assembled 
molecule (1). We currently report that c~ chains separated from 
collagen types V  and cartilage  la2a3a  inhibit type I binding 
but that the triple helical molecules formed from such chains 
are not inhibitory in the assays. We now conclude, therefore, 
that  tertiary  or quartenary  molecular structure  can critically 
modify the binding specificities of the collagens. 
Enzymatic removal of telopeptides  from native  unlabeled 
type  I  collagen did  not alter  its  capacity for inhibiting  125I- 
LRSC binding nor obviate the requirement  for thermal acti- 
vation of the ligand. 
Potential  binding sites  in  helical  al(I)  and  al(III) chains 
from  different  species  were  partially  mapped  by  testing  a 
limited number of cyanogen bromide-derived peptides  as in- 
hibitors. Inhibitory and noninhibitory peptides were thus iden- 
tified, and inhibitory activity was shown to be subject to species 
variation. As all of the peptides shared the repeating collagen 
triplet Gly-X-Y and were not much different in their content 
of proline  and  hydroxyproline,  these  elements  of collagen 
primary structure must be insufficient as determinants of bind- 
ing specificity.  Every al(I)  and  txl(III) chain  was  shown  to 
contain two or more inhibitory peptides and, considered as a 
group, such peptides were variously positioned in the chains. 
It seems reasonable to suppose that some or all of these regions 
contribute to binding determinants expressed by the assembled 
triple helical molecules. 
Fibronectin  is a  reasonable  candidate  as the molecule re- 
sponsible for the binding of collagens to the fibroblast surface. 
However, the ligand-binding specificities described above do 
not correspond to those reported for collagen-fibronectin inter- 
actions. In contrast to our data, fibronectin binds to the colla- 
genlike tail of acetylcholinesterase (21),  has different binding 
affinities for the various collagen types (22-24), and has been 
reported  to  bind  exclusively to  a  single  region  of the  td(I) 
chain (15).  Because of these discordancies and other data (1), 
we do not favor the view that fibronectin is responsible for the 
binding of native, soluble x2SI-LRSC to the fibroblast surface. 
The reported data are interpreted to mean that ligand deter- 
minants distributed  over the central collagen triple helix  are 
sufficient to bind  the  interstitial  procollagens  and  collagens 
(types I, II and III) to the fibroblast plasma membrane. Such 
binding is  proposed  as  an  in  vivo mechanism  for initiating 
fibril  assembly  and  for specifying  the  spatial  order  of that 
assembly (1, 2). The essential element of the hypothesis is that 
binding to a membrane component is determinate for fibrillo- 
genesis,  and  so  the  model  can  include  those  cases  where 
procollagen  fibrils  apparently  assemble  within  intraceUular 
vacuoles (25, 26).  The binding model allows for modulations 
of fibril  assembly by cell receptor metabolism  as well  as  by 
ligand-ligand interactions and, if there are independent binding 
sites  for each collagen type, the model provides a mechanism 
for segregation of type-specific fibrils.  The model assumes that, 
upon achieving a limiting size, the soluble surface-bound ag- 
gregates detach  from the cell and  that they then combine to 
form insoluble fibrils.  Perhaps it is at this later stage of fibril- 
logenesis that  collagen-fibronectin and  proteoglycan interac- 
tions become important. The binding model as formulated is 
quite compatible with proposals by others that type I collagen 
fibrils form by stepwise additions of molecular aggregates (see 
reference 27, for review). 
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